Interestingly, the resulting alternatively activated macrophage population is characterized by expression of markers (Ym1, Fizz1, Arg1) that previously have been attributed to a subset of pancreatic macrophages (usually described as Ym1+ macrophages) that drive fibrinogenesis and tumor progression (Liou et al., 2017). Here, RETNLB is linked to neoplasm.